NAMSA First to Receive FDA ASCA Accreditation for Medical Device Biocompatibility Testing
The ASCA Pilot Program , a first-of-its-kind conformity assessment program created by the U.S. FDA, reduces the regulatory burden on medical device manufacturers through consensus of biocompatibility testing requirements for efficiency.
- The ASCA Pilot Program , a first-of-its-kind conformity assessment program created by the U.S. FDA, reduces the regulatory burden on medical device manufacturers through consensus of biocompatibility testing requirements for efficiency.
- Founded in 1967 , NAMSA was the first independent company in the world to focus solely on testing medical device materials for safety.
- Today, the organization conducts over 100,000 tests annually to assist medical device innovators meet global testing requirements, mitigate biological risks and ensure medical device safety for end users.
- Helping medical device Sponsors improve healthcare since 1967, NAMSA is the only 100% medical device-focused, full continuum Contract Research Organization (CRO).